Table 3.
Characteristics |
PNS+ n=23 |
PNS− n = 27 |
p‐Value |
---|---|---|---|
Positive ANA | 23 (100%) | 27 (100%) | ‐ |
Positive anti‐Ro/SS‐A | 16 (70%) | 19 (70%) | .979 |
Positive anti‐La/SS‐B | 10 (43%) | 13 (48%) | .648 |
Rheumatoid factor | 13 (57%) | 18 (67%) | .665 |
Cryoglobulins | 3 (13%) | 7 (26%) | .668 |
Hypocomplementemia | 6 (26%) | 2 (7%) | .045 |
Hypergammaglobulinemia | 13 (57%) | 15 (56%) | .429 |
Hypogammaglobulinemia | 1 (4%) | 4 (15%) | .229 |
Monoclonal gammopathy | 1 (4%) | 1 (4%) | .543 |
Anemia (Hb < 12g/dl) | 9 (39%) | 10 (37%) | .879 |
Leukopenia (WBC < 4,000/mm3) | 7 (30%) | 11 (41%) | .449 |
Thrombocytopenia (PLT < 150,000/mm3) | 3 (13%) | 2 (7%) | .508 |
Hyperfibrinogenemia | 14 (61%) | 12 (44%) | .246 |
B−2‐microglobulin > 2.6 mg/L | 12 (52%) | 11 (41%) | .418 |
Positive anti‐CCP | 0 (0%) | 4 (41%) | .054 |
ESR > 30 mm/hr | 6 (26%) | 12 (44%) | .178 |
CRP > 5 mg/L | 4 (17%) | 6 (22%) | .670 |
Abbreviations: ANA antinuclear antibodies; CRP, C‐reactive protein; ESR, erythrocyte sedimentation rate; PNS−, patients without peripheral neuropathy; PNS+, patients with peripheral neuropathy; pSS, primary Sjögren's syndrome.
The results with statistical significance p<.05 are shown in bold.